Pharma Mar SA (PHM) Stock Statistics & Valuation Metrics

Pharma Mar SA has a market cap or net worth of $1.51B. The enterprise value is ―.

Pharma Mar SA has 18,222,227 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharma Mar SA’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 5.09%.

The current PE Ratio of Pharma Mar SA is 53.57. Pharma Mar SA’s PEG ratio is -2.70.

In the last 12 months, Pharma Mar SA had revenue of 174.85M and earned 26.13M in profits. Earnings per share was 1.48.

In the last 12 months, operating cash flow was -9.56M and capital expenditures -8.73M, giving a free cash flow of -18.29M billion.

Pharma Mar SA pays an annual dividend of €0.8, resulting in a dividend yield of 0.7%

Pharma Mar SA upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.

Pharma Mar SA as a current ratio of 3.03, with Debt / Equity ratio of 26.30%

In the past 12 months, Pharma Mar SA has paid -14.14M in taxes.

Pharma Mar SA EV to EBITDA ratio is 65.37, with an EV/FCF ratio of -146.31.

Pharma Mar SA has $140.85M in cash and marketable securities with €51.94M in debt, giving a net cash position of -$88.91M billion.

Gross margin is 94.41%, with operating margin of 3.70%, and net profit margin of 14.94%.

The average price target for Pharma Mar SA is $107.57, which is 11.43% higher than the current price. The consensus rating is Moderate Buy